Ned Kneeland, MD
Interventional Pain Medicine · Kalispell, MTNPI 1841388725
Payments from drug & device makers
Across 65 payments — averaging $43.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Pfizer$195
- Ipsen Biopharmaceuticals, Inc$144
- Avanos Medical$139
- Tersera Therapeutics LLC$61
- SPR Therapeutics, Inc$58
- plus $131 from 4 others
What the payments were for
- Food & beverage$1,30991%
- Education$1299%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 36 | $2,128 |
| Pfizer | 13 | $195 |
| Ipsen Biopharmaceuticals, Inc | 3 | $144 |
| Avanos Medical | 4 | $139 |
| Tersera Therapeutics LLC | 4 | $61 |
| SPR Therapeutics, Inc | 1 | $58 |
| Averitas Pharma Inc. | 1 | $58 |
| Pacira Therapeutics, Inc. | 1 | $29 |
| Stimwave Technologies Incorporated | 1 | $22 |
| AbbVie | 1 | $21 |
How this compares
Too few interventional pain medicine providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 39 | $21,104 |
| Xtampza ErOxycodone Myristate | 13 | $5,893 |
| Hysingla ErHydrocodone Bitartrate | 12 | $5,751 |
| Nortriptyline Hcl | 314 | $4,776 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 100 | $4,310 |
| Buprenorphine | 14 | $3,389 |
| Morphine Sulfate ErMorphine Sulfate | 77 | $3,261 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 136 | $2,422 |
| Hydromorphone Hcl | 109 | $2,387 |
| Fentanyl | 17 | $2,114 |
| Tramadol Hcl ErTramadol Hcl | 26 | $1,980 |
| Oxycodone Hcl | 61 | $1,796 |
| Morphine Sulfate | 42 | $1,545 |
| Tizanidine Hcl | 98 | $1,126 |
| Pregabalin | 49 | $1,051 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Kalispell
- Scott JahnkeKalispell$1K
- Saugat DeyGreat Falls$2K
- Eugene SlocumBozeman$692
- Samuel SpanbauerGreat Falls$77
- Ryan RugerBillings$34
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.